(1)
Zheng, Z. N.; Shen, X. H.; Ye, X. B.; Li, T.; Guo, J. Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates. World J Oncol 2026, 17 (2), 129-142. https://doi.org/10.14740/wjon2718.